Genesco (GCO) Tops Q4 EPS by 37c, Sales Slightly Lower; Guides In-Line
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $35.50 +0.97%
Revenue Growth %: -3.2%
Financial Fact:
Continuing operations: 1.3
Today's EPS Names:
OFLX, VAXX, NMRD, More
Revenue Growth %: -3.2%
Financial Fact:
Continuing operations: 1.3
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q4 EPS of $2.15, $0.37 better than the analyst estimate of $1.78. Revenue for the quarter came in at $883 million versus the consensus estimate of $900.35 million.
GUIDANCE:
Genesco sees FY2017 EPS of $4.40-$4.55, versus the consensus of $4.46.
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
